Citadel Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Citadel Advisors's VCYT Position: Q1 2026 in Review
Citadel Advisors reduced its Veracyte (VCYT) stake by 4.2% in Q1 2026, selling an estimated $249K and leaving 152,941 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #4362.
Citadel Advisors first reported a position in VCYT in Q4 2015 and has held it in 34 quarters since. The position peaked at $25.5M in Q1 2023. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Citadel Advisors held 152,941 shares of Veracyte worth $4.93M as of Q1 2026.
- Citadel Advisors sold 6,722 Veracyte shares in Q1 2026, an estimated $249K.
- Veracyte made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4362 holding.
- Citadel Advisors first reported a position in Veracyte in Q4 2015 and has held it in 34 quarters since.
- Citadel Advisors's Veracyte position peaked at $25.5M in Q1 2023.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.